Funding
MeuSIX is a Collaborative Project funded by the European Commission within its Seventh Framework Programme under the thematic area "Preclinical and/or clinical development of substances with a clear potential as orphan drugs" (HEALTH.2012.2.4.4-1).
Project full title: " Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder ". Grant agreement number: 304999. Duration: 5 years.